Drug Discovery

Clinical trials have long been a cornerstone of medical research, essential for the development and approval of new drugs and treatments. However, they are often plagued by high costs, time constraints, and the complexities associated with patient recruitment. In recent years, the transformative

The article delves into the intriguing potential of real-world evidence (RWE) to revolutionize the U.S. Food and Drug Administration’s (FDA) approval process for new drugs. By relying more on real-world data (RWD), regulatory decisions could become quicker, more economical, and maintain the current

Roche has recently entered into a groundbreaking multi-year collaboration with Oxford BioTherapeutics (OBT), valued at over a billion dollars, to spearhead the development of novel antibody-based cancer treatments. This significant partnership focuses on the creation of innovative therapies such as

Schrödinger, a well-established player in the computational chemistry and drug discovery space, has recently made headlines by embracing artificial intelligence (AI). The company’s CEO, Ramy Farid, officially announced this strategic pivot during the presentation of the company's year-end re

The pharmaceutical landscape is rapidly evolving, and at the forefront of these advancements is Merck & Co.'s groundbreaking licensing agreement with Jiangsu Hengrui Pharmaceuticals, focusing on the innovative Lipoprotein(a) [Lp(a)] inhibitor, HRS-5346. This monumental $2 billion deal puts

Google has long been at the forefront of technological innovation, and its efforts in the health sector are no exception. By leveraging advanced artificial intelligence (AI) capabilities, the tech giant aims to enhance global health outcomes through improved accessibility to quality health